Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 3

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Jan 21, 2017; 23(3): 540-546
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.540

Table 1 Patients’ characteristics

Characteristic	n (%)
Age (yr)
Median	58 (37-74)
Gender
Male	63 (82.9)
Female	13 (17.1)
Stage¹
II	21 (27.6)
III	27 (35.5)
IV	28 (30.3)
Fraction regimen
LCAF	16 (21.1)
CF	60 (78.9)
Number of chemotherapy cycles
1	8 (10.5)
2	13 (17.1)
3	7 (9.2)
4	48 (63.2)
Status
Survival	17 (22.4)
Dead	53 (69.7)
Lost to follow-up	6 (7.9)

¹UICC 6^th. LCAF: Late-course accelerated radiotherapy; CF: Conventional radiotherapy; UICC: Union for International Cancer Control.

Citation: Zhu HT, Ai DS, Tang HR, Badakhshi H, Fan JH, Deng JY, Zhang JH, Chen Y, Zhang Z, Xia Y, Guo XM, Jiang GL, Zhao KL. Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma. World J Gastroenterol 2017; 23(3): 540-546
URL: https://www.wjgnet.com/1007-9327/full/v23/i3/540.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i3.540

Zhu HT, Ai DS, Tang HR, Badakhshi H, Fan JH, Deng JY, Zhang JH, Chen Y, Zhang Z, Xia Y, Guo XM, Jiang GL, Zhao KL. Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma. World J Gastroenterol 2017; 23(3): 540-546 [PMID: 28210091 DOI: 10.3748/wjg.v23.i3.540]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.